This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Michael Mills, CEO of the award-winning Body and Mind Inc. BAMM BMMJ joined Benzinga’s Cannabis Capital Conference on April 21, 2022 to discuss investments relating to multi-state operations in the production, cultivation and retail sale of high quality, medical and recreational cannabis products.
Body and Mind (BaM)’s wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses ever. The company’s products include its award-winning strain of cannabis flower, edibles, oils and extracts.
Watch the full presentation here:
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Image via BaM | Body and Mind on Instagram
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.